Centessa Pharmaceuticals plc - ADR

NASDAQ:CNTA  
4.19
-0.08 (-1.87%)
Earnings Announcements

Centessa Pharmaceuticals Reports Fourth Quarter Net Loss Of $0.68 Per Share

Published: 03/30/2022 20:10 GMT
Centessa Pharmaceuticals plc - ADR (CNTA) - Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update.
Centessa Pharmaceuticals Plc - Company Expects Cash and Cash Equivalents Will Fund Operations Into Early 2024.
Centessa Pharmaceuticals Plc - Qtrly Net Loss per Ordinary Share - Basic and Diluted $0.68.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.60

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.65

More details on our Analysts Page.